Document is current
Any future updates will be listed below
-
Authors
Pearse, India
Corley, Amanda
Larsen, Emily N.
Rickard, Claire M.
Ware, Robert S.
Campbell, Jill
Coyer, Fiona
Alexandrou, Evan
O’Brien, Catherine
Marsh, Nicole
-
Funding
Funding for this research was provided by:
Eloquest Healthcare
- License Information
-
More Information
Article History
Received: 18 November 2021
Accepted: 21 April 2022
First Online: 12 May 2022
Declarations
:
: This trial has been approved by the Royal Brisbane and Women’s Hospital HREC (HREC/2021/QRBW/73896) and ratified by the University of Queensland HREC (2021/HE001361). This study was approved for both prospective consent or ‘consent to continue’ from either the patient or their substitute decision maker. All patients will be consented prior to their data being used in the trial analysis.
: A model consent form is available upon reasonable request to the corresponding author.
: CR: CR’s employers have received unrestricted investigator-initiated research or educational grants on CR’s behalf from product manufacturers (University of Queensland – Eloquest Healthcare; Griffith University – BD-Bard, Cardinal Health). Griffith University has received consultancy payments on CR’s behalf from manufacturers (3 M, BD-Bard). Griffith University received a donation of products on CR’s behalf from ICU Medical.All other authors do not have any competing interests to declare.
